Ivabradine: Difference between revisions
From IDWiki
(Created page with "== Dosing == * Heart failure ** Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >60 bpm after 2 weeks ** Decreases readmission but no mortality benef...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
* Heart failure |
* Heart failure |
||
** Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still > |
** Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >70 bpm after 2 weeks |
||
** Decreases readmission but no mortality benefit |
** Decreases readmission but no mortality benefit |
||
== Adverse Effects == |
|||
* Generally well-tolerated |
|||
* May have visual effects (flashing lights) |
|||
* Monitor QTc |
|||
[[Category:Medications]] |
[[Category:Medications]] |
||
Latest revision as of 18:04, 14 October 2021
Dosing
- Heart failure
- Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >70 bpm after 2 weeks
- Decreases readmission but no mortality benefit
Adverse Effects
- Generally well-tolerated
- May have visual effects (flashing lights)
- Monitor QTc
